Stephen LaHue Cartt, President and CEO at Asterias Biotherapeutics, Inc. (AST), bought 50,000 shares at $2.93 ($147K) on 2016-06-10, disclosed to the SEC on 2016-06-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| QCOR | BUY | 2012-11-06 | $242K | — | Filing → |
| QCOR | SELL | 2011-11-10 | $346K | — | Filing → |
| QCOR | SELL | 2011-11-01 | $6.8M | — | Filing → |